ERBB3 overexpression in GBM cells is caused by promoter methylation or miR-205 downregulation as an onco-suppressor (Figure 4) [122], resulting in a metabolic increase and PI3k/AKT/mTOR pathway hyperactivation [123] (Figure 2F). This evidence concerns the gene MTOR and glioblastoma.